The mission of the Cellular and Genetic Engineering Core (CGEC) is to empower biomedical researchers with advanced molecular cloning, viral vector production, and cellular engineering technologies that accelerate discovery across a wide range of disease-focused research programs. Co-directors are William Berry, Ph.D and Xi-Qin Ding, Ph.D.
CGEC partners with COBRE research program leaders, non-COBRE investigators, and the broader scientific community to design, build, and deliver customized genetic tools tailored to each project’s experimental needs. Through expert consultation, CGEC helps investigators select the most appropriate molecular platforms, design rigorous controls, and implement strategies that support both in vitro and in vivo studies.
Our core capabilities include the development of customized gene expression plasmids, AAV, retroviral, and lentiviral vector systems, CRISPR/Cas9-based knockout and knock-in cell lines, and specialized cellular platforms for BioID, NanoBRET, and NanoBiT assays. By combining technical expertise with collaborative project planning, CGEC enables researchers to investigate gene function, protein interactions, disease mechanisms, and therapeutic strategies with precision and reproducibility.
CGEC is committed to scientific collaboration, innovation, and resource sharing. Plasmids generated by the Core will be deposited with Addgene following publication, ensuring that valuable reagents are accessible to the broader research community and continue to support discoveries beyond individual projects.